STRS OHIO - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
STRS OHIO ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$485
-3.6%
89,000
+20.1%
0.00%0.0%
Q2 2023$503
-77.5%
74,100
-83.4%
0.00%
-33.3%
Q1 2023$2,235
+317.0%
446,400
+306.2%
0.00%
+50.0%
Q4 2022$536
-99.9%
109,900
+277.7%
0.00%0.0%
Q3 2022$419,000
+4.2%
29,100
+9.4%
0.00%0.0%
Q2 2022$402,000
+34.9%
26,600
+6.0%
0.00%
+100.0%
Q1 2022$298,000
-35.1%
25,100
+65.1%
0.00%
-50.0%
Q1 2021$459,000
-32.8%
15,200
+10.1%
0.00%
-33.3%
Q4 2020$683,000
+29.1%
13,8000.0%0.00%
+50.0%
Q3 2020$529,000
-27.9%
13,800
-18.8%
0.00%
-33.3%
Q2 2020$734,000
+19.3%
17,000
-28.0%
0.00%0.0%
Q1 2020$615,000
-16.6%
23,6000.0%0.00%0.0%
Q4 2019$737,000
-35.9%
23,600
-46.6%
0.00%0.0%
Q3 2019$1,150,000
+2574.4%
44,200
+2226.3%
0.00%
Q2 2019$43,000
-12.2%
1,9000.0%0.00%
Q1 2019$49,000
+28.9%
1,9000.0%0.00%
Q4 2018$38,0001,9000.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$1,041,9094.24%
Sofinnova Investments, Inc. 2,194,278$11,958,8150.75%
DENALI ADVISORS LLC 85,900$468,1550.16%
Polar Capital Holdings Plc 2,103,298$11,462,9740.08%
Soleus Capital Management, L.P. 157,182$856,6420.08%
GSA CAPITAL PARTNERS LLP 137,299$7480.06%
Caligan Partners LP 23,321$127,0990.06%
Corton Capital Inc. 12,244$66,7300.03%
RICE HALL JAMES & ASSOCIATES, LLC 91,249$497,3070.03%
CIM INVESTMENT MANAGEMENT INC 15,313$83,4560.03%
View complete list of Y-MABS THERAPEUTICS INC shareholders